Wednesday, March 22, 2023
THE SENIOR HEALTH LETTER
No Result
View All Result
  • Home
  • Home Care
  • Elder Care
  • Wellness
  • Dementia
  • Caregivers
  • Alzheimer’s
  • Assisted living
  • Mindfulness
  • Seniors advocate
The Senior Health Letter
No Result
View All Result
Home Alzheimer's

MRI Shows No Difference in Alzheimer’s Biomarkers in Patients Treated for Hypertension

Delmar by Delmar
March 12, 2021
in Alzheimer's
0
MRI Shows No Difference in Alzheimer’s Biomarkers in Patients Treated for Hypertension
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter


There aren’t any vital variations between the biomarkers for Alzheimer’s illness seen on the mind MRI scans of sufferers who’re both on normal remedy or intensive blood strain remedy, in response to new research outcomes.

In a research printed March 8 in JAMA Neurology, a crew of investigators from the College of Pennsylvania assessed mind MRI scans of those two teams of sufferers with hypertension. At comparability, they discovered nothing notable.

“There isn’t any constant or clinically significant distinction in magnetic resonance imaging biomarkers of Alzheimer’s illness between intensive and normal blood strain therapy,” wrote the crew led by Ilya Nasrallah, M.D., Ph.D., assistant professor of radiology on the Hospital of the College of Pennsylvania.

Particularly, the crew examined mind MRI scans from 454 sufferers with hypertension who had been a minimum of 50 years previous. Contributors underwent a baseline MRI with a follow-up scan in July 2016. Utilizing the scans, the crew in contrast adjustments in hippocampal quantity, measures of Alzheimer’s illness regional atrophy, posterior cingulate cerebral blood movement, and imply fractional anisotropy within the cingulum bundle.

In keeping with current literature, treating hypertension can play a job in decreasing the incidence of Alzheimer’s illness as vascular illness could be a part of kick-starting two biomarkers for the situation – hippocampal atrophy or delicate cognitive impairment. Nonetheless, no clear mechanism has been recognized to this point.

On the outset of this research, Nasrallah’s crew postulated the MRI scans would present much less change in hippocampal quantity and Alzheimer’s regional cortical thickness, signifying much less atrophy. As well as, they mentioned they anticipated a rise in posterior cingulate gyrus perfusion, in addition to a decline in fractional anisotropy within the cingulum bundle.

For this research, investigators enrolled 454 individuals who accomplished each MRI baseline scans that measured whole mind quantity, in addition to follow-up research. Common age at baseline was roughly 67 years, and roughly 40 % of the group had been girls. Blood strain was 138.1/77.9 mmHg, on common.

Primarily based on their evaluation, the crew noticed little distinction between the therapy teams when it got here to adjustments in hippocampal quantity. The intensive therapy group skilled a lower from 7.45 cm3 to 7.39 cm3 whereas the group receiving normal remedy noticed a discount from 7.48 cm3 to 7.46 cm3. In addition they noticed no indications of variations for different neurodegeneration markers which are typically thought of to be indicators of Alzheimer’s development.

The crew did word a number of limitations to their research along with the issue of even figuring out early adjustments in Alzheimer’s illness. The four-year follow-up time-frame might not have been lengthy sufficient, they mentioned, as Alzheimer’s is a very slow-developing illness.

However, adjustments are coming to, hopefully, facilitate analysis that may produce extra disease-modifying therapies. This will likely be notably necessary as a result of latest medical trial investigations for brand spanking new drug therapies have come up comparatively empty-handed, mentioned Susan Landau, Ph.D., affiliate analysis scientist, and Theresa Harrison, Ph.D., post-doctoral fellow, each of the Helen Wills Neuroscience Institute on the College of California at Berkeley.

In an accompanying editorial, they outlined two new methods that might probably assist investigators establish the underlying pathophysiology for Alzheimer’s. First, interventions are being launched earlier to pinpoint targets apart from irregular amyloid and tau proteins for particular person who’re at-risk however, but, unaffected. Second, giant, multi-site, longitudinal medical trials will nonetheless be integral as their outcomes might succeed the place epidemiological knowledge has not – they might unearth a causal hyperlink between hypertension and the mind, Landau and Harrison mentioned.

For extra protection based mostly on trade skilled insights and analysis, subscribe to the Diagnostic Imaging e-E-newsletter here.



Source link

Tags: AlzheimersBiomarkersDifferenceHypertensionMRIPatientsShowsTreated
Advertisement Banner
Previous Post

LETTER: Pushed off the trail | Regional-Perspectives | Opinion

Next Post

Virtual marketing, remote visits here to stay, senior living and care operators say – Business Daily News

Delmar

Delmar

Next Post
Virtual marketing, remote visits here to stay, senior living and care operators say – Business Daily News

Virtual marketing, remote visits here to stay, senior living and care operators say - Business Daily News

Discussion about this post

Recommended

Moving mindfulness from ‘me’ to ‘we’

Moving mindfulness from ‘me’ to ‘we’

2 years ago
Alzheimer’s and Dementia Care

Alzheimer’s and Dementia Care

2 years ago

Don't Miss

(2021-2026) Nursing Home Beds Market Size, Demand Status | Global Industry Segment Analysis, Growing Status of Key Players

Advice You Need To Know About Personal Development

May 12, 2021
Asceneuron Receives USD 2.2 Million Award from the Alzheimer’s Drug Discovery Foundation

Advocate Aurora Enterprises acquires national leader in home care and wellness offerings Senior Helpers

April 1, 2021
‘I’m in jail’: BPS mothers and caregivers voice concerns with district reopening plans

‘I’m in jail’: BPS mothers and caregivers voice concerns with district reopening plans

April 1, 2021
As Loved Ones Reunite After A Year, Dementia Experts Offer These Tips

As Loved Ones Reunite After A Year, Dementia Experts Offer These Tips

April 1, 2021

Categories

  • Alzheimer's
  • Assisted living
  • Caregivers
  • Dementia
  • Elder Care
  • Home Care
  • Mindfulness
  • Seniors advocate
  • Uncategorized
  • Wellness

Follow us

Recent News

(2021-2026) Nursing Home Beds Market Size, Demand Status | Global Industry Segment Analysis, Growing Status of Key Players

Advice You Need To Know About Personal Development

May 12, 2021
Asceneuron Receives USD 2.2 Million Award from the Alzheimer’s Drug Discovery Foundation

Advocate Aurora Enterprises acquires national leader in home care and wellness offerings Senior Helpers

April 1, 2021
March 2021
S M T W T F S
 123456
78910111213
14151617181920
21222324252627
28293031  
    Apr »
  • About Us
  • Contact Us
  • Privacy & Policy

© 2021 The Senior health Letter

No Result
View All Result
  • Home
  • Home Care
  • Elder Care
  • Wellness
  • Dementia
  • Caregivers
  • Alzheimer’s
  • Assisted living
  • Mindfulness
  • Seniors advocate

© 2021 The Senior health Letter